12:00 AM
Dec 08, 2014
 |  BioCentury  |  Finance

Fast funding for Chinese healthcare innovators

How Chinese healthcare VC firm TF Capital is investing first fund

TF Capital plans to invest its inaugural China-focused VC fund in innovation and technology in that nation's healthcare space. The firm, which has about $50 million to invest, has already made about eight investments, including last week's $10 million series A round for in-licensing play Canbridge Life Sciences Ltd.

"The whole healthcare sector has changed with the booming middle class, and we see a big opportunity here," said...

Read the full 324 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >